Clinical Trial Update: Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study of a new anticoagulant drug in patients with atrial fibrillation. Sponsor is ARYx Therapeut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• New Anticoagulant Drug

Snippet

Sponsor: ARYx Therapeutics | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED